Elanco Animal Health INC Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
NYSE
Kapila K Anand, a Director of Elanco Animal Health Inc, received 642 shares of common stock on September 30, 2026.
NYSE
Jeffrey N Simmons, PRESIDENT, CEO AND DIRECTOR and a Director of Elanco Animal Health Inc, received 126 shares of common stock on September 18, 2026.
NYSE
Rajeev A. Modi, SEE REMARKS of Elanco Animal Health Inc, received 66 shares of common stock on September 18, 2026.
NYSE
Robert M Vanhimbergen, EVP and CFO of Elanco Animal Health Inc, received 9 shares of common stock on September 18, 2026.
NYSE
Robert M Vanhimbergen, EVP and CFO of Elanco Animal Health Inc, received 8 shares of common stock on September 4, 2026.
NYSE
Rajeev A. Modi, SEE REMARKS of Elanco Animal Health Inc, received 60 shares of common stock on September 4, 2026.
NYSE
Jeffrey N Simmons, PRESIDENT, CEO AND DIRECTOR and a Director of Elanco Animal Health Inc, received 115 shares of common stock on September 4, 2026.
NYSE
Rajeev A. Modi, SEE REMARKS of Elanco Animal Health Inc, received 62 shares of common stock on August 21, 2026.
NYSE
Robert M Vanhimbergen, EVP and CFO of Elanco Animal Health Inc, received 8 shares of common stock on August 21, 2026.
NYSE
Jeffrey N Simmons, PRESIDENT, CEO AND DIRECTOR and a Director of Elanco Animal Health Inc, received 118 shares of common stock on August 21, 2026.
NYSE
Lawrence Erik Kurzius, a Director of Elanco Animal Health Inc, purchased 40,000 shares of common stock on August 20, 2026 for $23.40 per share.
NYSE
Shiv O'Neill, GC AND CORP SEC of Elanco Animal Health Inc, purchased 3,998 shares of common stock on August 18, 2026 for $23.58 per share.
NYSE
Michael J Harrington, a Director of Elanco Animal Health Inc, purchased 5,000 shares of common stock on August 12, 2026 for $21.82 per share.
NYSE
Jeffrey N Simmons, PRESIDENT, CEO AND DIRECTOR and a Director of Elanco Animal Health Inc, received 128 shares of common stock on August 7, 2026.
NYSE
Robert M Vanhimbergen, EVP and CFO of Elanco Animal Health Inc, purchased 4,200 shares of common stock on August 7, 2026 for $23.08 per share.
NYSE
Rajeev A. Modi, SEE REMARKS of Elanco Animal Health Inc, received 67 shares of common stock on August 7, 2026.
NYSE
Paul Herendeen, a Director of Elanco Animal Health Inc, purchased 10,000 shares of common stock on August 7, 2026 for $23.68 per share.
NYSE
Jeffrey N Simmons, PRESIDENT, CEO AND DIRECTOR and a Director of Elanco Animal Health Inc, received 113 shares of common stock on July 24, 2026.
NYSE
Rajeev A. Modi, SEE REMARKS of Elanco Animal Health Inc, received 59 shares of common stock on July 24, 2026.
NYSE
Robert M Vanhimbergen, EVP and CFO of Elanco Animal Health Inc, received 8 shares of common stock on July 24, 2026.
NYSE
Jeffrey N Simmons, PRESIDENT, CEO AND DIRECTOR and a Director of Elanco Animal Health Inc, received 114 shares of common stock on July 10, 2026.
NYSE
Rajeev A. Modi, SEE REMARKS of Elanco Animal Health Inc, received 60 shares of common stock on July 10, 2026.
NYSE
Elanco Animal Health Inc. reports a transaction by its EVP and CFO, Robert M. VanHimbergen, involving the acquisition of common stock.
NYSE
David S. Kinard, an executive at Elanco Animal Health Inc., was granted stock options with a vesting schedule spanning three years.
NYSE
Director Kapila K. Anand has elected to defer her director cash retainer fees into Elanco Animal Health Inc. stock units.
NYSE
Jeffrey N. Simmons, President, CEO, and Director of Elanco Animal Health Inc., reported a transaction involving deferred stock units.
NYSE
Robert M. VanHimbergen, EVP and CFO of Elanco Animal Health Inc., reported a transaction involving deferred stock units.
NYSE
Robert M. VanHimbergen, EVP and CFO of Elanco Animal Health Inc., reported a transaction involving deferred stock units.
NYSE
Elanco Animal Health CEO Jeffrey N. Simmons acquired 116.9603 deferred stock units on June 12, 2026, valued at $24.17 per unit.
NYSE
Rajeev A. Modi, Executive Vice President at Elanco Animal Health, reported a transaction involving deferred stock units on June 12, 2026.